1. FDA approval brings first gene therapy to the United States [Internet]. 2017. Available from: https://www.fda.gov/news-events/press-announcements/fda-approval-brings-first-gene-therapy-united-states
2. FDA approves CAR-T cell therapy to treat adults with certain types of large B-cell lymphoma [Internet]. 2017. Available from: https://www.fda.gov/news-events/press-announcements/fda-approves-car-t-cell-therapy-treat-adults-certain-types-large-b-cell-lymphoma
3. FDA Approves First Cell-Based Gene Therapy For Adult Patients with Relapsed or Refractory MCL [Internet]. 2020. Available from: https://www.fda.gov/news-events/press-announcements/fda-approves-first-cell-based-gene-therapy-adult-patients-relapsed-or-refractory-mcl
4. FDA approves lisocabtagene maraleucel for relapsed or refractory large B-cell lymphoma [Internet]. 2021. Available from: https://www.fda.gov/drugs/drug-approvals-and-databases/fda-approves-lisocabtagene-maraleucel-relapsed-or-refractory-large-b-cell-lymphoma
5. CAR T cell immunotherapy for human cancer;June;Science,2018